Let’s start with the obvious: Artificial intelligence is no longer a futuristic concept waiting to enter healthcare. It is already changing how diseases are detected, how medical information is analyzed, and how clinicians make decisions.
The question before us, however, is no longer whether AI belongs in healthcare — It is whether we will deploy it responsibly enough to make healthcare more personal, proactive, and accessible.
The scale of the transformation is difficult to ignore. The U.S. Food and Drug Administration’s (FDA) public database contained more than 1,250 AI-enabled medical devices by July 2025, up substantially from roughly 950 the year before. Market researchers now project the U.S. healthcare AI market could reach approximately $222.9 billion by 2033, representing a 36.9% compound annual growth rate from 2026 onward.
But the most important innovation, in my view, is for a society seismically shifting to adopt a new philosophy about who owns, understands, and benefits from healthcare data.
That is where organizations such as BAiO can help point the way.
Healthcare generates enormous quantities of information, from medical histories, imaging, laboratory results, wearable-device readings, treatment outcomes, and behavioral data. Historically, much of this information has been fragmented across institutions and systems. AI today gives us the opportunity to transform those disconnected data points into actionable intelligence.
Imagine a healthcare ecosystem in which a patient’s information is not simply stored, but continuously interpreted to identify patterns, flag potential risks, and support earlier intervention. Instead of waiting for the disease to become symptomatic, physicians could increasingly use AI-enabled systems to identify warning signals before a crisis occurs.
That is the promise of AI-powered, data-driven healthcare: moving from reactive medicine toward predictive and preventive care.
BAiO’s work is particularly relevant to this evolution because healthcare innovation should ultimately be measured by whether technology improves the individual patient experience, not simply by how sophisticated the underlying technology appears.
The greatest opportunity lies in combining artificial intelligence with human expertise. AI can process enormous datasets at speeds no individual clinician can match. It can identify correlations, summarize complex information, and support diagnostic and treatment decisions. But it cannot replace the empathy, judgment, and accountability that define the physician-patient relationship.
The World Health Organization has recognized both the promise and risks of AI in health, including its potential applications in pharmaceutical development and delivery. Meanwhile, researchers and policymakers continue to raise legitimate concerns about bias, privacy, transparency, and overreliance on automated systems.
The answer is not to slow innovation. It is to build trust into innovation from the beginning.
That means protecting patient data.
It means validating algorithms across diverse populations.
It means giving clinicians visibility into how AI-generated recommendations are produced.
And, it means establishing clear lines of responsibility when technology influences a medical decision.
The FDA is already confronting this challenge. But one month ago, the agency was reported to be exploring a competency-based approach to evaluating generative AI medical devices — an indication that conventional regulatory models may need to evolve alongside increasingly sophisticated technology.
For healthcare leaders, this should be viewed as an opportunity rather than an obstacle.
The future will belong to systems that combine the computational power of AI with the humanity of medicine. It will belong to organizations willing to treat data not merely as an institutional asset, but as a tool for empowering patients and improving outcomes.
AI should not make healthcare less human.
THE COMPUTER SAID NO: HOW INVISIBLE BANK ALGORITHMS ARE LOCKING OUT SMALL BUSINESSES
It should give physicians more time to be physicians, give patients a greater understanding of their own health, and give healthcare systems the intelligence to intervene earlier.
That is the real promise of the AI revolution in medicine. And it is a future we should build deliberately, responsibly, and with the patient at its center.
Dr. Chirag Patel is an ESPN Medical Commentator and founder and CEO of BAiO.